Literature DB >> 12698166

First experiences with the stable prostacyclin analog iloprost in the evaluation of heart transplant candidates with increased pulmonary vascular resistance.

Armin Sablotzki1, Elke Czeslick, Ekkehard Gruenig, Ivar Friedrich, Susann Schubert, Jochen Börgermann, Thomas Hentschel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12698166     DOI： 10.1067/mtc.2003.49

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  2 in total

1.  A retrospective comparison of inhaled milrinone and iloprost in post-bypass pulmonary hypertension.

Authors:  Kassiani Theodoraki; Apostolos Thanopoulos; Panagiota Rellia; Evangelos Leontiadis; Dimitrios Zarkalis; Konstantinos Perreas; Theophani Antoniou
Journal:  Heart Vessels       Date:  2017-07-17       Impact factor: 2.037

2.  PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support.

Authors:  Ryan J Tedford; Anna R Hemnes; Stuart D Russell; Ilan S Wittstein; Mobusher Mahmud; Ari L Zaiman; Stephen C Mathai; David R Thiemann; Paul M Hassoun; Reda E Girgis; Jonathan B Orens; Ashish S Shah; David Yuh; John V Conte; Hunter C Champion
Journal:  Circ Heart Fail       Date:  2008-11       Impact factor: 8.790
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.